Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Idle

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
Journal of Periodontal Research|September 1, 1993
Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowthJ S Ellis, R A Seymour, S Monkman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
The kinetics of the auto-induction of ifosfamide metabolism during continuous infusionA V Boddy, M Cole, A D Pearson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1994
Potential inhibition of alkylating agent metabolism by fluconazoleS M Yule, D Walker, A D Pearson, et al.
British Journal of Clinical Pharmacology|January 1, 1980
Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]A Bababunmi, J R Idle, A Mahgoub, et al.
Ciba Foundation Symposium|January 1, 1980
Toxicological implications of polymorphic drug metabolismJ C Ritchie, T P Sloan, J R Idle, et al.
Methods in Enzymology|January 1, 1996
CYP2D6 multiallelismA K Daly, V M Steen, K S Fairbrother, et al.
Lancet (London, England)|April 4, 1981
Genetically determined impaired drug sulphoxidationR H Waring, S C Mitchell, J R Idle, et al.
Human Genetics|March 1, 1995
An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitutionA K Daly, J B Leathart, S J London, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
Genetic polymorphism of phenformin 4-hydroxylationN S Oates, R R Shah, J R Idle, et al.
Journal of the National Cancer Institute|November 18, 1992
Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamideA V Boddy, Y Furtun, S Sardas, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
Journal of Periodontal Research|September 1, 1993
Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowthJ S Ellis, R A Seymour, S Monkman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
The kinetics of the auto-induction of ifosfamide metabolism during continuous infusionA V Boddy, M Cole, A D Pearson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1994
Potential inhibition of alkylating agent metabolism by fluconazoleS M Yule, D Walker, A D Pearson, et al.
British Journal of Clinical Pharmacology|January 1, 1980
Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]A Bababunmi, J R Idle, A Mahgoub, et al.
Ciba Foundation Symposium|January 1, 1980
Toxicological implications of polymorphic drug metabolismJ C Ritchie, T P Sloan, J R Idle, et al.
Methods in Enzymology|January 1, 1996
CYP2D6 multiallelismA K Daly, V M Steen, K S Fairbrother, et al.
Lancet (London, England)|April 4, 1981
Genetically determined impaired drug sulphoxidationR H Waring, S C Mitchell, J R Idle, et al.
Human Genetics|March 1, 1995
An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitutionA K Daly, J B Leathart, S J London, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
Genetic polymorphism of phenformin 4-hydroxylationN S Oates, R R Shah, J R Idle, et al.
Journal of the National Cancer Institute|November 18, 1992
Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamideA V Boddy, Y Furtun, S Sardas, et al.
Pageof 20